1. Systemic 8-OH-DPAT challenge causes hyperventilation largely via activating pre-botzinger complex 5-HT 1A receptors.
- Author
-
Zhuang J and Xu F
- Subjects
- 8-Hydroxy-2-(di-n-propylamino)tetralin administration & dosage, Animals, Disease Models, Animal, Male, Medulla Oblongata drug effects, Piperazines pharmacology, Pyridazines pharmacology, Rats, Receptor, Serotonin, 5-HT1A drug effects, Respiratory Center drug effects, 8-Hydroxy-2-(di-n-propylamino)tetralin pharmacology, GABA Antagonists pharmacology, Hyperventilation chemically induced, Hyperventilation drug therapy, Medulla Oblongata metabolism, Receptor, Serotonin, 5-HT1A physiology, Respiratory Center metabolism, Serotonin 5-HT1 Receptor Antagonists pharmacology, Serotonin Receptor Agonists pharmacology
- Abstract
Systemic 8-OH-DPAT (a 5-HT
1A receptor agonist) challenge evokes hyperventilation independent of peripheral 5-HT1A receptors. Though the pre-Botzinger Complex (PBC) is critical in generating respiratory rhythm and activation of local 5-HT1A receptors induces tachypnea via disinhibition of local GABAA neurons, its role in the respiratory response to systemic 8-OH-DPAT challenge is still unclear. In anesthetized rats, 8-OH-DPAT (100 μg/kg, iv) was injected twice to confirm the reproducibility of the evoked responses. The same challenges were performed after bilateral microinjections of (S)-WAY-100135 (a 5-HT1A receptor antagonist) or gabazine (a GABAA receptor antagonist) into the PBC. Our results showed that: 1) 8-OH-DPAT caused reproducible hyperventilation associated with hypotension and bradycardia; 2) microinjections of (S)-WAY-100135 into the PBC attenuated the hyperventilation by ˜60 % without effect on the evoked hypotension and bradycardia; and 3) the same hyperventilatory attenuation was also observed after microinjections of gabazine into the PBC. Our data suggest that PBC 5-HT1A receptors play a key role in the respiratory response to systemic 8-OH-DPAT challenge likely via disinhibiting local GABAergic neurons., (Copyright © 2021 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF